. . "After considering factors such as low CD4 count and BMI, researchers found a trend toward greater vitamin D deficiency in people who had taken non-nucleoside reverse transcriptase inhibitors (NNRTIs), such as Viramune (nevirapine) and Sustiva (efavirenz) compared with protease inhibitors." . . .